エピソード

  • Shared Decision-Making in Epilepsy Today

    Shared Decision-Making in Epilepsy Today
    2025/06/30

    How do you talk to patients about conception, risks to offspring during epilepsy treatment, mortality, lifestyle and brain health?

    Credit available for this activity expires: 6/27/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002600?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    52 分
  • Frontline Frontiers: Revolutionizing Extensive-Stage SCLC Care Through Treatment Innovation

    Frontline Frontiers: Revolutionizing Extensive-Stage SCLC Care Through Treatment Innovation
    2025/06/30

    Are you up-to-date on the novel, practice-changing combination strategies for first-line maintenance treatment?

    Credit available for this activity expires: 6/13/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002626?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    36 分
  • Navigating PD-L1 Testing and Patient-Centered Treatment of Gastroesophageal Cancer: A Guide for All Oncology Settings

    Navigating PD-L1 Testing and Patient-Centered Treatment of Gastroesophageal Cancer: A Guide for All Oncology Settings
    2025/06/30

    Do you know why programmed death-ligand 1 (PD-L1) testing and targeted therapy are so important for improving patient care?

    Credit available for this activity expires: 6/27/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002597?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    49 分
  • Under the Skin: Revolutionizing Immunotherapy Delivery in Lung Cancer

    Under the Skin: Revolutionizing Immunotherapy Delivery in Lung Cancer
    2025/06/25

    How ready are you to optimally manage subcutaneous immunotherapy in your practice?

    Credit available for this activity expires: 6/25/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002630?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    16 分
  • One Team, One Goal: The Key to Better Patient Outcomes in Early Breast Cancer Management

    One Team, One Goal: The Key to Better Patient Outcomes in Early Breast Cancer Management
    2025/06/06

    Are you up to date with management strategies for early breast cancer?

    Credit available for this activity expires: 06/03/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002593?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    38 分
  • Collaborative Management of EGFR-Mutated Advanced NSCLC: A Patient–Care Team Journey

    Collaborative Management of EGFR-Mutated Advanced NSCLC: A Patient–Care Team Journey
    2025/05/30
    How well are you managing your patients with the new intensification strategies for EGFR-mutated advanced non-small cell lung cancer (NSCLC)? Credit available for this activity expires: 5/29/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002547?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    51 分
  • New Considerations in Managing Family Planning in Multiple Sclerosis

    New Considerations in Managing Family Planning in Multiple Sclerosis
    2025/05/08

    What are the key challenges that women with multiple sclerosis (MS) face during their pregnancy journey?

    Credit available for this activity expires: 4/30/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002489?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    55 分
  • Advancing Precision Oncology: Recent Progress and Future Outlook

    Advancing Precision Oncology: Recent Progress and Future Outlook
    2025/05/01

    Did you know that there are several approved tumor agnostic therapies? Join our experts for an in-depth discussion.

    Credit available for this activity expires: 04/30/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-precision-oncology-recent-progress-and-future-2025a1000a6b?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    39 分